Neoplasms Metastasis Completed Phase 3 Trials for Irinotecan (DB00762)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01996306A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRCTreatment
NCT00144378Irinotecan Versus Only Best Supportive Care for Gastric Cancer
NCT00561470Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based RegimenTreatment